Safety, tolerability, pharmacokinetics, and efficacy of AZD3759 in EGFR-mutant NSCLC with CNS metastases

Reports from phase 1, open-label, dose-escalation and dose-expansion study
Reports from phase 1, open-label, dose-escalation and dose-expansion study